[1]
Rubio-Terrés, C. et al. 2014. Cost analysis of the adverse reactions of bipolar disorder treatment with aripiprazole and olanzapine in Spain. Actas Españolas de Psiquiatría. 42, 5 (Sep. 2014), 242–249.